Theratechnologies Preclinical Data Presentation at AACR 2024

Novel camptothecin-peptide conjugates are well tolerated and associated with significant tumor regression in colorectal cancer and triple-negative breast cancer xenograft modelsSORT1 gene silencing results in drastic decrease in peptide-drug conjugate

Related Keywords

United States , Montreal , Quebec , Canada , San Diego , California , China , American , Chinese , Borhane Annabi , Julie Schneiderman , Philippe Dubuc , Twitter , Company Phase , American Association For Cancer Research , Communications Corporate Affairs , Chemistry Department , Linkedin , Theratechnologies Inc , American Association , Cancer Research , Senior Vice President , Chief Medical Officer , Cancer Prevention , Sudocetaxel Zendusortide , Fast Track , Forward Looking Statements , Looking Statements , Vice President , Chief Financial , Taacr , Dc , Peptide Drug Conjugate , Colorectal Cancer , Nbc , Dancer , Ncology , Rumors , Health , Medication ,